2026 Blue Rx PDP Complete (PDP) formulary (drug list)
Contract S5593, plan 003 · West Virginia · 3,788 drugs on file · formulary ID 00026017. Each drug links to its cost in every CMS PDP Region 06 plan.
43 drugs starting with K.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| KAITLIB FE KitNorethindrone And Ethinyl Estradiol | 2Generic | $5.00 | $12.50 | None |
| KALETRA 80/20 mg/mL SolutionLopinavir And Ritonavir | 5Specialty Tier | 25% | N/A | None |
| KALYDECO 13.4 mg GranuleIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KALYDECO 150 mg Tablet, Film CoatedIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KALYDECO 25 mg GranuleIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KALYDECO 5.8 mg GranuleIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KALYDECO 50 mg GranuleIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KALYDECO 75 mg GranuleIvacaftor | 5Specialty Tier | 25% | N/A |
|
| KARIVA KitDesogestrel/Ethinyl Estradiol And Ethinyl Estradiol | 2Generic | $5.00 | $12.50 | None |
| KELNOR 1/35 KitEthynodiol Diacetate And Ethinyl Estradiol | 2Generic | $5.00 | $12.50 | None |
| KERENDIA 10 mg Tablet, Film CoatedFinerenone | 4Non-Preferred Drug | 25% | 25% |
|
| KERENDIA 20 mg Tablet, Film CoatedFinerenone | 4Non-Preferred Drug | 25% | 25% |
|
| KERENDIA 40 mg TabletFinerenone | 4Non-Preferred Drug | 25% | 25% |
|
| KESIMPTA 20 mg/.4mL Injection, SolutionOfatumumab | 5Specialty Tier | 25% | N/A |
|
| KETOCONAZOLE 20 mg/g CreamKetoconazole Cream, 2% | 2Generic | $5.00 | $12.50 |
|
| KETOCONAZOLE 20 mg/mL Shampoo, Suspension | 2Generic | $5.00 | $12.50 |
|
| KETOCONAZOLE 200 mg Tablet | 2Generic | $5.00 | $12.50 | None |
| KETOPROFEN 200 mg Capsule, Extended Release | 2Generic | $5.00 | $12.50 | None |
| KETOPROFEN 25 mg Capsule | 2Generic | $5.00 | $12.50 | None |
| KETOPROFEN 50 mg Capsule | 2Generic | $5.00 | $12.50 | None |
| KETOROLAC TROMETHAMINE 10 mg Tablet, Film Coated | 2Generic | $5.00 | $12.50 | None |
| KETOROLAC TROMETHAMINE 4 mg/mL Solution/ Drops | 2Generic | $5.00 | $12.50 | None |
| KETOROLAC TROMETHAMINE 5 mg/mL Solution | 2Generic | $5.00 | $12.50 | None |
| KINERET 100 mg/.67mL Injection, SolutionAnakinra | 5Specialty Tier | 25% | N/A |
|
| KINRIX 25/10/25/8/25/40/8/32 [iU]/.5mL/ug/.5mL Injection, SuspensionDiphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine | 3Preferred Brand | 25% | 25% | None |
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KLISYRI 10 mg/g OintmentTirbanibulin | 5Specialty Tier | 25% | N/A |
|
| KLOR-CON 1.5 g Powder, For SolutionPotassium Chloride | 4Non-Preferred Drug | 25% | 25% | None |
| KLOR-CON 600 mg Tablet, Film Coated, Extended ReleasePotassium Chloride | 3Preferred Brand | 25% | 25% | None |
| KLOR-CON 750 mg Tablet, Film Coated, Extended ReleasePotassium Chloride | 3Preferred Brand | 25% | 25% | None |
| KLOR-CON M 1125 mg Tablet, Extended ReleasePotassium Chloride | 1Preferred Generic | $0.00 | $0.00 | None |
| KLOR-CON M 1500 mg Tablet, Extended ReleasePotassium Chloride | 1Preferred Generic | $0.00 | $0.00 | None |
| KLOR-CON M 750 mg Tablet, Extended ReleasePotassium Chloride | 1Preferred Generic | $0.00 | $0.00 | None |
| KLOXXADO 8 mg/.1mL SprayNaloxone Hcl | 3Preferred Brand | 25% | 25% | None |
| KOSELUGO 10 mg CapsuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 25 mg CapsuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 5 mg GranuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 7.5 mg GranuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOURZEQ 1 mg/g PasteTriamcinolone Acetonide | 2Generic | $5.00 | $12.50 | None |
| KRAZATI 200 mg Tablet, CoatedAdagrasib | 5Specialty Tier | 25% | N/A |
|
| KURVELO KitLevonorgestrel And Ethinyl Estradiol | 2Generic | $5.00 | $12.50 | None |
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.